General MedicationsTOPICALGeneric
EFINACONAZOLE
EFINACONAZOLE
Standard Dose
10%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview EFINACONAZOLE is listed in Drugs@FDA under application 212178 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EFINACONAZOLE Form and strength SOLUTION;TOPICAL - 10% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2024-06-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview EFINACONAZOLE is listed in Drugs@FDA under application 212178 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EFINACONAZOLE Form and strength SOLUTION;TOPICAL - 10% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2024-06-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.